期刊文献+

癫痫诊治中医患同盟建立的实践与策略 被引量:3

Practice and Tactic of Establishing Doctor-patient Ally in Diagnosis and Therapy of Epilepsy
下载PDF
导出
摘要 癫痫治疗目前仍以长期科学规范的药物治疗为主,为保证医生的治疗计划得到贯彻,在诊治中努力寻求医患同盟的建立尤为重要,让患者清楚地认识到医生对他的关注,认识到医生治疗的计划性、和具有应对各种情况的措施方法和能力,是寻求患方合作的基本条件。本文就医生首诊中的任务、人文关怀的重要性、如何共同进行药物选择、副反应规避、家属不良治疗心态纠正等问题进行探讨。 To explore the way of establishing doctor - patient ally , so that the scheme of antlepileptic therapy can be carried out successfully. Doctors should let patients know clearly that they are concerned anout them, their treatment plans are complete and they have ability to deal with any kinds of medical situations, which is basic condition to achieve patients' cooperation. According to medical wok in diagnosis and treatment of epilepsy in the past few years,explore clinical practice and theory tactic in the problems as follows: the task of first diagnosis, importance of humanistic care,methods of selecting a proper drug together with patients and their family , avoiding side effects, rectifying wrong psychological state of patients' family during therapy, and so on.
作者 宋凡 许晶
出处 《医学与哲学(B)》 2007年第2期36-38,共3页 Medicine & Philosophy(B)
关键词 癫痫 药物治疗 医患同盟 epilepsy, drug treatment, doctor-patient ally
  • 相关文献

参考文献2

二级参考文献25

  • 1Cacek AJ. Review of alterations in oral phenytoin bioavailability associated with formulation, antacids and foos. Ther Drug Monit,1986, 8: 166-171.
  • 2Degen PH, Flech G, Cardot JM, et al. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers. Biopharm Drug Dispos, 1994, 15: 519-526.
  • 3Doose DR, Walker SA, Gisclon LG. Single - dose pharmacokinetic of food on the bioavailabilability of topiramate, a novel antiepileptic drug.J Clin Pharmacol, 1996, 36: 884-891.
  • 4Perucca E, Richens A. General principles: biotransformation . In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptie drags. 4thed. New York: Raven Press, 1995, 31-50.
  • 5Anderon GD. A mechanistic approach to antiepileptie drug interactions. Ann Pharmacother, 1998, 32: 554-563.
  • 6Schater SC, Oxcarbazepine: current status and clinical aplications. Exp Opin Invest Drugs, 1999, 8:1103 - 1112.
  • 7Baruzzi A, Albani F, Riva R, et al. Oxcarbazepine: phannacokinetic interaction and their clinical relevance. Epilepsia, 1993, 35: S14- 19.
  • 8May TW, Rambeck B, Jurgens U. Influence of oxcarbazepine and methsuximide on lamotrigine concentration in epileptic patients with and without valproic acid comedication: results of a retro spective study. Ther Drug Monit, 1999, 21:1751-81.
  • 9Anderson GD, Yau MK, Gidai BE, et el. Bidirectional interaction of valproate and lamotrigine in healthy subjects. Clin Pharmacol Ther 1996;60:145 -56.
  • 10Kerrick JM, Wolff DL, Graves NM. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparisnn of two prediction methods. Ann Pharmacother 1995 ;29:470 - 4.

共引文献20

同被引文献6

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部